Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 7,394 | 3,741 | 25,650 | 10,287 | 47,885 |
| Gross Profit | 7,394 | 3,741 | 25,650 | 10,287 | 47,885 |
| Operating Expenses | 88,149 | 75,865 | 76,575 | 68,118 | 67,197 |
| Operating Income | -80,755 | -72,124 | -50,925 | -57,831 | -19,312 |
| Interest Expense | 59 | 60 | 61 | 69 | 52 |
| Other Income | 10,062 | 9,697 | 8,924 | 9,343 | 4,996 |
| Pre-tax Income | -70,752 | -62,487 | -42,062 | -48,557 | -14,368 |
| Net Income Continuous | -70,752 | -62,487 | -42,062 | -48,557 | -14,368 |
| Net Income | $-70,752 | $-62,487 | $-42,062 | $-48,557 | $-14,368 |
| EPS Basic Total Ops | -0.89 | -0.82 | -0.58 | -0.69 | -0.25 |
| EPS Basic Continuous Ops | -0.90 | -0.82 | -0.58 | -0.69 | -0.24 |
| EPS Diluted Total Ops | -0.89 | -0.82 | -0.58 | -0.69 | -0.25 |
| EPS Diluted Continuous Ops | -0.90 | -0.82 | -0.58 | -0.69 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.88 | -0.82 | -0.58 | -0.69 | N/A |
| EBITDA(a) | $-82,035 | $-73,760 | $-53,008 | $-59,442 | $-19,690 |